ArticleJournal of family medicine and primary care2025
Microalbuminuria in normotensive nondiabetic overweight and obese versus nonobese adults.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Propensity score analysis of triglyceride-glucose index in newly diagnosed patients with essential hypertension as a predictor of microalbuminuria.Frontiers in endocrinology · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Obesity has reached an epidemic stage worldwide. As the prevalence of obesity increases, the burden of its associated comorbidities increases. It has been linked to altered hemodynamics leading to glomerulopathy that results in microalbuminuria, proteinuria, and chronic kidney disease. Recent population-based surveys have shown that overweight and obesity are the risk factors for the development and progression of nephropathy in normotensive and nondiabetic adults as well. The underlying causes may involve adipogenic inflammation and endothelial dysfunction that results in microalbuminuria. The population of the Asia Pacific region appears to be at higher risk of obesity-related morbidities at lower BMI. An established indicator of early renal impairment in diabetes and hypertension is microalbuminuria (MAU). Our study aims to screen obese and overweight adults and compare them with nonobese adults to estimate the prevalence of microalbuminuria in both groups when risk factors such as diabetes and hypertension are excluded. Material and Methods: This study was a comparative cross-sectional study carried out in a tertiary care hospital from January 2021 to May 2022. An appropriate statistical method was applied to calculate the sample size. A total of 75 obese individuals were taken as cases and 75 age- and sex-matched nonobese adults as controls were taken for the study. Results and Conclusion: The prevalence of microalbuminuria was found to be 24% in cases compared to 5.33% in controls, which was statistically significant, with a
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.